Prevalence of beta-lactam allergy: a retrospective chart review of drug allergy assessment in a predominantly pediatric population
- PMID: 27956906
- PMCID: PMC5129666
- DOI: 10.1186/s13223-016-0165-6
Prevalence of beta-lactam allergy: a retrospective chart review of drug allergy assessment in a predominantly pediatric population
Abstract
Background: Research suggests that 90% of patients labeled beta-lactam allergic are able to tolerate penicillins following further assessment. This study aims to define and describe the frequency of true beta-lactam allergy following allergy patient evaluation in a predominantly pediatric population.
Methods: 306 primary care patients referred between January 2010 and June 2015 were assessed for a suspected beta-lactam allergy. Patient demographics, history and test results were extracted from electronic medical records. Testing performed was based on specialist recommendation following review of patient history.
Results: 34% of the study participants had intradermal testing. Oral challenge was given to 96.7% of the sample. 96% of patients with a prior history of beta-lactam allergy were advised that they could re-introduce beta-lactam antibiotics following evaluation.
Conclusions: Among patients with a documented beta-lactam allergy or a recent history of a reaction there is a low rate of 'true' beta-lactam allergy. Consistent evaluation of beta-lactam antibiotic allergies can reduce rates of broad spectrum antibiotic prescribing, among other harmful consequences.
Keywords: Anaphylaxis; Beta-lactam allergy; Drug allergy, adverse drug reaction.
Figures
References
-
- Joint Task Force on Practice Parameters American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol. 2010;105(4):259–273. doi: 10.1016/j.anai.2010.08.002. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
